447 related articles for article (PubMed ID: 18990139)
1. Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis.
Bolenz C; Fernández MI; Trojan L; Hoffmann K; Herrmann E; Steidler A; Weiss C; Ströbel P; Alken P; Michel MS
BJU Int; 2009 Apr; 103(8):1040-6. PubMed ID: 18990139
[TBL] [Abstract][Full Text] [Related]
2. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.
Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L
Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.
Fernández MI; Bolenz C; Trojan L; Steidler A; Weiss C; Alken P; Grobholz R; Michel MS
Eur Urol; 2008 Mar; 53(3):571-8. PubMed ID: 17804149
[TBL] [Abstract][Full Text] [Related]
4. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
[TBL] [Abstract][Full Text] [Related]
5. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma.
Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D
J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845
[TBL] [Abstract][Full Text] [Related]
6. Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis.
Miyata Y; Kanda S; Ohba K; Nomata K; Eguchi J; Hayashida Y; Kanetake H
J Urol; 2006 Jul; 176(1):348-53. PubMed ID: 16753442
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
[TBL] [Abstract][Full Text] [Related]
8. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density.
Bolenz C; Shariat SF; Fernández MI; Margulis V; Lotan Y; Karakiewicz P; Remzi M; Kikuchi E; Zigeuner R; Weizer A; Montorsi F; Bensalah K; Wood CG; Roscigno M; Langner C; Koppie TM; Raman JD; Mikami S; Michel MS; Ströbel P
BJU Int; 2009 Feb; 103(3):302-6. PubMed ID: 18990164
[TBL] [Abstract][Full Text] [Related]
10. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.
Remzi M; Haitel A; Margulis V; Karakiewicz P; Montorsi F; Kikuchi E; Zigeuner R; Weizer A; Bolenz C; Bensalah K; Suardi N; Raman JD; Lotan Y; Waldert M; Ng CK; Fernández M; Koppie TM; Ströbel P; Kabbani W; Murai M; Langner C; Roscigno M; Wheat J; Guo CC; Wood CG; Shariat SF
BJU Int; 2009 Feb; 103(3):307-11. PubMed ID: 18990163
[TBL] [Abstract][Full Text] [Related]
11. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract.
Kikuchi E; Horiguchi Y; Nakashima J; Hatakeyama N; Matsumoto M; Nishiyama T; Murai M
J Urol; 2005 Dec; 174(6):2120-3; discussion 2124. PubMed ID: 16280740
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
[TBL] [Abstract][Full Text] [Related]
13. Lymphangiogenesis in gastric carcinoma correlates with prognosis.
Gao P; Zhou GY; Zhang QH; Su ZX; Zhang TG; Xiang L; Wang Y; Zhang SL; Mu K
J Pathol; 2009 Jun; 218(2):192-200. PubMed ID: 19224540
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma.
Bolenz C; Fernández MI; Trojan L; Herrmann E; Becker A; Weiss C; Alken P; Ströbel P; Michel MS
Urology; 2008 Aug; 72(2):364-9. PubMed ID: 18579189
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.
Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J
Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866
[TBL] [Abstract][Full Text] [Related]
16. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G
Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic microvessel density is an independent prognostic factor in colorectal cancer.
Matsumoto K; Nakayama Y; Inoue Y; Minagawa N; Katsuki T; Shibao K; Tsurudome Y; Hirata K; Nagata N; Itoh H
Dis Colon Rectum; 2007 Mar; 50(3):308-14. PubMed ID: 17164964
[TBL] [Abstract][Full Text] [Related]
18. The aggressiveness of urothelial carcinoma depends to a large extent on lymphovascular invasion--the prognostic contribution of related molecular markers.
Afonso J; Santos LL; Amaro T; Lobo F; Longatto-Filho A
Histopathology; 2009 Nov; 55(5):514-24. PubMed ID: 19912357
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated lymphangiogenesis in the development of conjunctival squamous cell carcinoma.
Heindl LM; Hofmann-Rummelt C; Adler W; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2010 Apr; 117(4):649-58. PubMed ID: 20346821
[TBL] [Abstract][Full Text] [Related]
20. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?
Brown GA; Busby JE; Wood CG; Pisters LL; Dinney CP; Swanson DA; Grossman HB; Pettaway CA; Munsell MF; Kamat AM; Matin SF
BJU Int; 2006 Dec; 98(6):1176-80. PubMed ID: 17125474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]